216 related articles for article (PubMed ID: 23528424)
1. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
[TBL] [Abstract][Full Text] [Related]
2. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
[TBL] [Abstract][Full Text] [Related]
3. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
[TBL] [Abstract][Full Text] [Related]
4. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
5. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.
Benítez J; Guggeri L; Tomaz I; Arrambide G; Navarro M; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2009 Apr; 103(4):609-16. PubMed ID: 19091422
[TBL] [Abstract][Full Text] [Related]
6. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
7. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
[TBL] [Abstract][Full Text] [Related]
8. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
[TBL] [Abstract][Full Text] [Related]
9. Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of
Scalese G; Machado I; Salinas G; Pérez-Díaz L; Gambino D
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500808
[TBL] [Abstract][Full Text] [Related]
10. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
11. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
[TBL] [Abstract][Full Text] [Related]
12. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
[TBL] [Abstract][Full Text] [Related]
13. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
[TBL] [Abstract][Full Text] [Related]
15. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fluorination on the Structure and Anti-
Salsi F; Bulhões Portapilla G; Simon S; Roca Jungfer M; Hagenbach A; de Albuquerque S; Abram U
Inorg Chem; 2019 Aug; 58(15):10129-10138. PubMed ID: 31310108
[TBL] [Abstract][Full Text] [Related]
17. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H
Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and application of vanadium-salan complexes in oxygen transfer reactions.
Adão P; Costa Pessoa J; Henriques RT; Kuznetsov ML; Avecilla F; Maurya MR; Kumar U; Correia I
Inorg Chem; 2009 Apr; 48(8):3542-61. PubMed ID: 19290614
[TBL] [Abstract][Full Text] [Related]
20. Monomeric oxovanadium(IV) compounds of the general formula cis-[V(IV)(=O)(X)(L(NN))(2)](+/0) [X = OH(-), Cl(-), SO(4)(2)(-) and L(NN) = 2,2'-bipyridine (bipy) or 4,4'-disubstituted bipy].
Triantafillou GD; Tolis EI; Terzis A; Deligiannakis Y; Raptopoulou CP; Sigalas MP; Kabanos TA
Inorg Chem; 2004 Jan; 43(1):79-91. PubMed ID: 14704056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
